NDHAN Alert Healthcare Providers are Reminded to Think Measles
NDHAN: Ebola Outbreak, Uganda Provider Information
NDHAN Health Advisory: Severe Respiratory Illnesses Associated with Rhinoviruses and/or Enteroviruses Including EV-D68 - Multistate, 2022
NDHAN Update on COVID-19 therapeutics (8/8/2022)
NDHAN Monkeypox Management in Certain Patient Populations
NDHAN: Health Advisory Human Parechovirus (PeV) Infections in Neonates and Young Infants
NDHAN: Health Advisory Update to Monkeypox Testing Availability and North Dakota Vaccine Allocation
NDHAN: Health Advisory Syphilis on the Rise
NDHAN: Monkeypox Update for Providers
NDHAN: COVID-19 Rebound after Paxlovid treatment
NDHAN: Monkeypox in the United States and Other Countries
NDHAN Update: Guidance for Adenovirus Testing and Typing of Patients Under Investigation - Pediatric Acute Hepatitis of Unknown Etiology
NDHAND: Health Alert Update on treatments for mild-to-moderate COVID-19
NDHAN Detection of HPAI H5N1 in Colorado Patient
NDHAN: Health Advisory Call for Case Reports - Pediatric Acute Hepatitis of Unknown Etiology
NDHAN: Testing, treatment and infection control recommendations for providers managing patients with confirmed or suspected avian influenza
NDHAN: Health Advisory Update to COVID-19 laboratory reporting requirements to public health: Effective April 4, 2022.
NDHAN: Health Advisory Update on Evusheld
NDHAN: Health Advisory National Shortage of Rifampin Capsules
NDHAN: Health Advisory Abbott Recalls Infant Formulas Concerning Infections with Cronobacter sp. and Salmonella sp.
NDHAN: Health Advisory HSS UPdate on COVID-19 therapeutics
NDHAN: Health Advisory FDA Approves First Injectable Treatment for Pre-Exposure Prophylaxis (PrEP)
Download alert (pdf)
NDHAN: Health Advisory Update: Omicron Variant Update
Download alert (pdf)
Download COVID-19 Outpatient Therapeutics Decision Guide (pdf)
NDHAN: Health Advisory Update: Omicron and COVID-19 Therapies
NDHAN: Health Advisory Monoclonal Antibody and Antiviral Updates
NDHAN: Health Advisory Omicron (5.1.1.529) Variant Update North Dakota
NDHAN: Health Advisory Update on the Omicron Variant and Influenza Activity
NDHAN: Health Advisory FDA expands authorization of two monoclonal antibodies for treatment and post-exposure prevention of COVID-19 to younger pediatric patients, including newborns.
NDHAN: Health Advisory New SARS-CoV-2 Variant of Concern Identified: Omicron (B.1.1.529) Variant
NDHAN: Health Update Influenza Update, 2021-2022 Influenza Season
NDHAN: Health Advisory Update on Monoclonal Antibody Shipments for Week of Nov 1
NDHAN: Health Advisory Melioidosis Update: Possible Source Identified
NDHAN: Health Advisory Expansion of Recall of LeadCare Blood Lead Tests Due to Risk of Falsely Low Results
NDHAN Health Advisory Update on Monoclonal Antibody Shipments for week of October 11
NDHAN: Health Advisory Update on Monoclonal Antibody Shipment
NDHAN: Health Advisory Update on Monoclonal Antibody Shipments for Week of October 4
NDHAN: Health Advisory Update on Pregnancy and COVID-19 Vaccinations
NDHAN: Health Advisory Pregnancy and COVID-19 Vaccinations
NDHAN: Health Advisory Respiratory Illness Surveillance and Diagnostic Testing: Influenza, COVID-19, and other respiratory Pathogens
NDHAN: Health Advisory Information for Awareness and Action for People Arriving from Afghanistan
NDHAN: Health Advisory for Rescinding Interim Guidance for Tuberculosis Testing and COVID-19 Vaccine.
NDHAN: Health Advisory for MaGellan Diagnostics, Inc LeadCare Blood Lead Test Recall Expansion
NDHAN: Health Advisory for the use of Ivermectin for treatment or prophylaxis against COVID-19
NDHAN: Health Advisory CDC Releases Updated STI Treatment Guidelines
NDHAN: Health Update on SARS-CoV-2 Delta Variant and Other Variants of Concern
NDHAN: Health Advisory Monkey Pox Alert for the United States
NDHAN: Health Alert Meliodosis reported from three states
NDHAN: Health Advisory Magellan Diagnostics, Inc LeadCare Blood Lead Test Recall
NDHAN: Health Update on SARS-CoV-2 Variants of Concern, Testing and Treatment for COVID-19
NDHAN: Health Advisory Pause in Administration of Johnson and Johnson COVID-19 Vaccine
NDHAN: Health Advisory COVID-19 Breakthrough Cases
NDHAN: Health Advisory CDC Extensively Drug-Resistant Salmonella Typhi Infections Among U.S. Residents Without International Travel
NDHAN: Health Advisory Interim Guidance for Tuberculosis Testing and COVID-19 Vaccine: 0119202101rd
Download alert (pdf)
Health Advisory for New Recommended Treatment for Gonococcal Infections:
Download alert (pdf)
Outpatient COVID-19 Infusion Therapy or Monoclonal Antibodies and other Potential COVID-19 Infusion Therapies
Download alert (pdf)
This is a North Dakota Health Alert message. Please find attached a Health Advisory for Treatment for Tuberculosis—Nitrosamine Impurities in Rifampin & Rifapentine. Please distribute this information as you see fit.
Download alert (pdf)
This is a North Dakota Health Alert message. Please find attached a Health Advisory for COVID-19 Reinfection Assessment and Investigation. Please distribute this information as you see fit.
Download alert (pdf)
This is a North Dakota Health Alert message. Please find attached a Health Advisory for COVID-19 Antigen Testing Guidance. Please distribute this information as you see fit.
Download alert (pdf)
NDHAN: Health Advisory National Shortage of STI Test Kits and Laboratory Supplies
Download alert (pdf)
This is a North Dakota Health Alert message. Please find attached a Health Advisory for Ciprofloxacin Resistant Neisseria meningitidis Serogroup Y. Please distribute this information as you see fit.
Download alert (pdf)
This is a North Dakota Health Alert message. Please find attached a Health Advisory for COVID-19 Diagnostic Testing Guidance. Please distribute this information as you see fit.
Download alert (pdf)
NDHAN: Health Advisory Community Health partnership to plan and execute COVID-19 testing: ID 0520202001rd
Download alert (pdf)
NDHAN: Health Advisory for Pediatric Multisystem Inflammatory Syndrome in Children ID# 0515202001rd
Download alert (pdf)
STATE OF NORTH DAKOTA HOSPITAL SURGE PLAN AND VULNERABLE POPULATION PROTECTION PLAN (VP3) 2020 COVID-19 PANDEMIC RESPONSE.
Download alert (pdf)
NDHAN: 0506202001rd Health Alert for Battelle N-95 Decontamination No Charge (5/6/2020)
Health Alert for Battelle N-95 Decontamination Summary
Download alert (pdf)
Health Alert for Battelle N-95 Decontamination Sign Up
Download alert (pdf)
Discontinuation of Isolation for COVID-19
Download alert (pdf)
Health Advisory for COVID-19 Testing and Reporting Guidance
Download alert (pdf)
This is a North Dakota Health Alert message. Please do not discard N95 masks. There are several processes available to decontaminate the masks and a number of hospitals have this capability. The CDC recommends that users store used N95 masks in a breathable container, that is well marked (to prevent accidental use), and according to the manufacturer’s recommendations for temperature and moisture. Additional guidance from the Department of Health will be forthcoming relative to the decontamination and reuse of N95 masks. Please see CDC guidance in the interim: https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/decontaminat… Please contact Nicole Brunelle with any questions: nbrunelle@nd.gov]nbrunelle@nd.gov
Download alert (pdf)
NDHAN: 0407202003rd Health Advisory for COVID-19 Testing Update Abbott M2000 Testing
Download alert (pdf)
NDHAN: 0331202005rd COVID-19 HCW Screening protocol
Download alert (pdf)
NDHAN: 0331202005rd COVID-19 Chloroquine
Download alert (pdf)
NDHAN: 0331202005rd COVID-19 HCW Travel Guidance
Download alert (pdf)